New in MMWR: Use of Doxycycline Postexposure Prophylaxis to Prevent STIs

[Date Prev][Date Next][Thread Prev][Thread Next][Date Index][Thread Index]



MMWR banner

June 6, 2024

RECOMMENDATIONS AND REPORTS

The graphic shows the MMWR Recommendations and Report logo on a purple background.

CDC Clinical Guidelines on the Use of Doxycycline Postexposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention, United States, 2024


Recent trials indicate that 200 mg of doxycycline taken within 72 hours after sex reduces syphilis, chlamydia, and gonococcal infections. This report outlines CDC’s recommendation for the use of doxycycline postexposure prophylaxis (doxy PEP).

PDF of this report (link)

CONTINUING EDUCATION

This image shows children walking into a classroom and one child giving their teacher a high-five.

New MMWR Medscape CE Activity on Vaccination Coverage and Exemption Rates Among Kindergartners.

PODCAST

This figure is an image of a microphone on a dark background with sound waves and the text “MMWR Weekly Briefing,” representing the MMWR podcast.

MMWR Weekly Briefing Podcast: Week of May 6


The latest MMWR Weekly Briefing is live. Topics include: Shiga toxin-producing E. coli in Utah, travel-associated malaria along the southern border, and more. Listen and subscribe on: Apple Podcasts and Spotify.

Centers for Disease Control and Prevention

1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348
Questions or Problems  | 


[Index of Archives]     [NIH News]     [FDA News]     [USDA News]     [Yosemite News]     [Steve's Art]     [SB Lupus]     [STB]
  Powered by Linux